At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 17, 2026 at 16:32 ET
Two Dexcom insiders (a director and an EVP) sold a combined $410K in open-market transactions over a one-week window ending June 15, 2026. The total value represents approximately 0.0015% of Dexcom's $28.2B market cap, making these trades trivial in proportion and likely reflecting routine portfolio diversification or tax planning rather than a bearish signal.
- Director Mark G. Foletta sold 3,801 shares for $282K on June 15, 2026.
- EVP & Chief Legal Officer Michael J. Brown sold 1,700 shares for $128K on June 15, 2026.
- Total insider sales of $410K represent less than 0.002% of Dexcom's $28.2B market capitalization.
- No insider buying occurred in the same window; both transactions were open-market sales.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access